Molecular Targeting Technologies (United States)

mtarget.com

biotechnology company focused on the development of diagnostic and therapeutic molecules to address the medical needs in cancer and cardiovascular diseases. Lead product candidates include PSVue and Tc-99m Duramycin. MTTI is also building a research reagents business and manufactures and sells an ever expanding portfolio of products, primarily based upon fluorescence, to meet the needs of cutting edge academic researchers